卵巢癌FIGO分期2018（适用于卵巢癌、输卵管癌、腹膜癌）

TNM

FIGO

TX

Primary tumor cannot be assessed

原发肿瘤不可评估

T0

No evidence of primary tumor

没有原发肿瘤

T1

Ⅰ

Tumor limited to ovaries (one or both) or fallopian tube(s)

肿瘤局限于卵巢（单侧或者双侧）或者输卵管。

T1a

ⅠA

Tumor limited to one ovary (capsule intact) or

fallopian tube, no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings

肿瘤局限于单侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。

T1b

ⅠB

Tumor limited to both ovaries; (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings

肿瘤局限于双侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。

T1c

ⅠC

Tumor limited to one or both ovaries or fallopian

tubes, with any of the following:

肿瘤局限于单侧或双侧卵巢或者输卵管，合并以下任一情况：

T1c1

ⅠC1

Surgical spill

术中肿瘤破裂

T1c2

ⅠC2

Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface

术前肿瘤自发破裂，或者卵巢或输卵管表面有肿瘤

T1c3

ⅠC3

Malignant cells in ascites or peritoneal washings

腹水或腹腔冲洗液有恶性细胞（细胞学阳性）

T2

Ⅱ

Tumor involves one or both ovaries or fallopian tubes with pelvic extension below pelvic brim or primary peritoneal cancer

肿瘤累及单侧或双侧卵巢或输卵管，伴盆腔内扩散未超出盆腔上缘或者原发性腹膜癌（局限于盆腔内）

T2a

ⅡA

Extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries

子宫和/或输卵管和/或卵巢的扩散和/或种植（未超出子宫双附件）

T2b

ⅡB

Extension to and/or implants on other pelvic tissues

扩散和/或种植到盆腔内其他组织（超出子宫双附件）

T3

Ⅲ

Tumor involves one or both ovaries or fallopian tubes, or primary peritoneal cancer, with microscopically confirmed peritoneal metastasis outside the pelvis and/or metastasis to the retroperitoneal (pelvic and/or para-aortic) lymph nodes

肿瘤累及一侧或双侧卵巢或输卵管，或原发性腹膜癌，伴有镜下证实的盆腔外腹膜转移和/或腹膜后(盆腔和/或腹主动脉旁)淋巴结转移 （肿瘤累及盆腔以外）

T1/T2 N1

ⅢA1

Positive retroperitoneal lymph nodes only (histologically confirmed)

仅腹膜后阳性淋巴结(组织学证实)

T1/T2

N1a

ⅢA1i

Metastasis up to and including 10 mm in greatest dimension

仅腹膜后淋巴结阳性，病灶最大直径≤10mm

T1/T2

N1b

ⅢA1ii

Metastasis more than 10 mm in greatest dimension

仅腹膜后淋巴结阳性，病灶最大直径＞10mm

T3a

ⅢA2

Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes

镜下肿瘤超出盆腔腹膜（骨盆上缘以上），伴或不伴腹膜后淋巴结阳性

T3b

ⅢB

Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the etroperitoneal lymph nodes

盆腔外腹膜肉眼可见肿瘤转移灶，最大直径≤2cm，伴或不伴腹膜后淋巴结转移

T3c

ⅢC

Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)

盆腔外腹膜可见肿瘤转移灶最大直径＞2cm，伴或不伴腹膜后淋巴结转移（包括肝包膜、脾包膜的肿瘤，没有任何脏器实质的受累。）

M1

Ⅳ

Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine

远处转移，包括胸腔积液细胞学阳性、肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯。

M1a

ⅣA

Pleural effusion with positive cytology

胸腔积液细胞学阳性

M1b

ⅣB

Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine

肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯